Search Results

In GPCR drug discovery, a single mistaken assumption can derail an entire program. Terry Kenakin reframes one of pharmacology’s most foundational ideas: the difference between competitive Inside the Lesson: Antagonist Behavior by the Numbers Terry walks through both the pharmacologic and If you want to avoid costly misinterpretations and strengthen your pharmacology toolkit, Terry’s Corner Brief today  ➤   #GPCRantagonism #CompetitiveAntagonists #NonCompetitiveAntagonists #DoseResponseCurve #Pharmacology

Terry's Corner - New Course on Pharmacologic Models The latest Terry’s Corner unlocks clinical forecasting in the full newsletter   Secure Your Access Now ➤ 🗣️ “Thank you for bringing this (Principles of Pharmacology GPCR University Learner Dr. GPCR Podcast - Surviving Discovery’s Gauntlet Dr. Listen Now – Real Lessons from a GPCR Expert ➤ The future of GPCR isn’t waiting. GPCR Team Read Full Edition ➤

For over two decades, my work has centered on GPCR pharmacology . The GPCR Data Dilemma: The Lego Bucket Problem I've seen promising GPCR programs generate massive volumes My Approach: Biology, Execution, Systems My consulting approach uniquely blends deep pharmacology expertise GPCR As the co-founder of Dr. GPCR, we've built a global hub connecting over 1,300 GPCR scientists dedicated to this field.

Advanced data analysis for GPCR pharmacology Dr. Samuel Hoare Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

pharmacology Data ❌ Suboptimal CRO Partnerships ❌ Stalled Pipeline Progression ❌ Uncertainty in GPCR Actionable Scientific Validation: Ensure target companies execute the right GPCR pharmacology experiments Biology-First, Data-Driven Solutions Every recommendation is rooted in GPCR biology, pharmacology experience With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

GPCR Podcast << Back to podcast list Strategic Partners Dr. Shivani Sachdev About Dr. Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable